Efficacy and Safety of Direct Oral Anticoagulants in Patients with Cirrhosis-- Single Institution Experience

Conclusions:Our study is the largest series of patients with cirrhosis treated with DOACs. Bleeding complications with DOAC use in this population is high. Providers considering starting DOACs in patients with cirrhosis should consider the risk of bleeding in this population.DisclosuresNo relevant conflicts of interest to declare.

Source: Blood - November 21, 2018 Category: Hematology Authors: Cisak, K. I., Asante, D., Grill, D. E., Ashrani, A. A. Tags: 332. Antithrombotic Therapy: Poster II Source Type: research